Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Mottok

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|November 13, 2012
Mapping immune processes in intact tissues at cellular resolutionChristian Brede, Mike Friedrich, Ana-Laura Jordán-Garrote, et al.
Cancer Cell|April 25, 2020
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin LymphomaElie Dheilly, Elena Battistello, Natalya Katanayeva, et al.
Genome Biology|February 28, 2015
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsEmilia L Lim, Diane L Trinh, David W Scott, et al.
Blood|February 6, 2014
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphomaDavid D W Twa, Fong Chun Chan, Susana Ben-Neriah, et al.
Blood Advances|June 10, 2020
Gene expression profiling of gray zone lymphomaClémentine Sarkozy, Lauren Chong, Katsuyoshi Takata, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Blood|February 25, 2018
High-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements with diffuse large B-cell lymphoma morphologyDavid W Scott, Rebecca L King, Annette M Staiger, et al.
Blood|July 12, 2019
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphomaAnja Mottok, Stacy S Hung, Elizabeth A Chavez, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 11, 2020
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor PrognosisElizabeth Punnoose, Franklin V Peale, Edith Szafer-Glusman, et al.
Cell|October 4, 2016
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T CellsMichael Boice, Darin Salloum, Frederic Mourcin, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|November 13, 2012
Mapping immune processes in intact tissues at cellular resolutionChristian Brede, Mike Friedrich, Ana-Laura Jordán-Garrote, et al.
Cancer Cell|April 25, 2020
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin LymphomaElie Dheilly, Elena Battistello, Natalya Katanayeva, et al.
Genome Biology|February 28, 2015
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsEmilia L Lim, Diane L Trinh, David W Scott, et al.
Blood|February 6, 2014
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphomaDavid D W Twa, Fong Chun Chan, Susana Ben-Neriah, et al.
Blood Advances|June 10, 2020
Gene expression profiling of gray zone lymphomaClémentine Sarkozy, Lauren Chong, Katsuyoshi Takata, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Blood|February 25, 2018
High-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements with diffuse large B-cell lymphoma morphologyDavid W Scott, Rebecca L King, Annette M Staiger, et al.
Blood|July 12, 2019
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphomaAnja Mottok, Stacy S Hung, Elizabeth A Chavez, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 11, 2020
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor PrognosisElizabeth Punnoose, Franklin V Peale, Edith Szafer-Glusman, et al.
Cell|October 4, 2016
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T CellsMichael Boice, Darin Salloum, Frederic Mourcin, et al.
Pageof 9